Reducing Metabolic risk associated with coronary artery disease; controlling dietary components in diabetes patients.

Pending

controlling diet will reduce metabolic syndrome in diabetes patients
controlling metabolic syndrome will reduce the risk of coronary artery disease risk score.

0 - 2 - 4 - 6 months

Control Arm

Participants randomized into the control group did not receive unsolicited feedback but will continue to receive their usual medical care as per usual when visiting their doctors but are allowed to contact the research facilitator as necessary. Participants in all three groups were required to monitor their blood glucose at least once daily (as per schedule). Glucose readings were taken daily as per schedule and performed 5 days a week throughout the six-months of study duration. At the end of study (six-months) participants of control arm were compared with Pharmacist intervention arm and telemonitoring arm for glycemic control and other relevant outcomes.



Pharmacist Intervention Arm:

Participants were referred through their primary physician or clinic nurses. Further screening was conducted to ensure eligibility for participation in this study.

Diabetes education that includes (i) diabetes disease process (ii) nutrition and physical exercise (iii) self-monitoring (iv) diabetes complications will be provided to participants who have provided a written informed consent. Participant baseline assessment included (i) past medical history (ii) demographic questionnaire and symptom questionnaire (iii) concomitant medication (iv) physical examination such as weight, height (v) blood specimen including HbA1c, etc.

Eligible participants were provided with a systemic booklet and home-work book to record their daily activities. Also researcher has developed a weekly glucose-monitoring schedule. Participants have to report daily physical activity and eating habits as well. A registered pharmacist provide once weekly visit to participant home for monitoring and evaluation (also provide counselling).